Empagliflozin
Green
Brand:
Jardiance®
Nice TA:
336
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Empagliflozin is recommended as a treatment for type 2 diabetes when taken with metformin, only if :
-
sulfonylurea cannot be taken or
-
is at significant risk of hypoglycaemia or its consequences.
If a person needs to take 3 antidiabetic drugs, empagliflozin is recommended as a treatment for type 2 diabetes when taken with either metformin and a sulfonylurea, or with metformin and a thiazolidinedione.
Empagliflozin is also recommended as a treatment for type 2 diabetes when taken with insulin, with or without other antidiabetic drugs.
The LSCMMG recommends empagliflozin as a 1st line ““gliflozin””.
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: